Meloxicam Azevedos

Meloxicam, the active ingredient in Meloxicam Azevedos, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for systemic use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain in adult patients.

GNH USA supplies Meloxicam Azevedos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal disorders. - Osteoarthritis: alleviates joint pain and improves mobility by decreasing synovial inflammation. - Rheumatoid arthritis: moderates chronic joint inflammation and limits disease‑related stiffness. - Ankylosing spondylitis: reduces spinal pain and inflammatory markers, enhancing functional capacity. - Acute pain: provides rapid analgesia for short‑term musculoskeletal injuries or postoperative discomfort.

Meloxicam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or mild abdominal pain. - Headache: transient tension‑type headaches. - Dizziness: occasional light‑headedness, especially on standing. - Edema: mild peripheral swelling, often in the ankles. - Elevated liver enzymes: transient increases detected in routine labs.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding: may present as black stools or vomiting blood. - Cardiovascular events: increased risk of myocardial infarction or stroke, particularly with long‑term use. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Renal impairment: acute kidney injury manifested by reduced urine output. - Hepatotoxicity: jaundice or marked liver enzyme elevation.

Before prescribing Meloxicam, clinicians should assess patient history and comorbidities. - Cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension. - Gastrointestinal safety: use cautiously in individuals with a history of ulcers or bleeding disorders. - Renal function: monitor serum creatinine in patients with chronic kidney disease. - Hepatic health: check liver function tests periodically, especially in those with pre‑existing liver disease. - Pregnancy and lactation: avoid unless benefits outweigh potential risks, as safety data are limited. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture and direct sunlight.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: may potentiate nephrotoxic effects. - Lithium: NSAIDs can raise serum lithium levels, necessitating monitoring.